DGAP-Adhoc: Pulsion Medical Systems SE raises buy-volume in conjunction with share buy-back


Pulsion Medical Systems SE  / Key word(s): Share Buyback

03.05.2012 11:31

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

PULSION Medical Systems SE raises buy-volume in conjunction with share
buy-back

Munich, May 03, 2012 - The Administrative Board of PULSION Medical Systems
SE, Munich, ISIN DE0005487904 // WKN 548790, has decided to raise the
volume of shares to be bought back in conjunction with the Company's share
buy-back above the original level of 200,000 shares to 280,521 shares.

In accordance with the final notification of shares offered, dated April
30, 2012, a total of 280,521 shares have been offered to the Company for
buy-back. The Company has resolved to purchase all of the shares offered.




Contact:

Investor Relations
PULSION Medical Systems SE
Ralph Schäfer
Director Legal Affairs 
Tel.: +49 (0)89 / 459914 211 
Fax: +49 (0)89 / 459914 481 
E-mail: schaefer@pulsion.com


03.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Pulsion Medical Systems SE
              Joseph-Wild-Strasse 20
              81829 München
              Germany
Phone:        +49 (0)89 4599 14-0
Fax:          +49 (0)89 4599 14-18
E-mail:       info@pulsion.com
Internet:     www.pulsion.com
ISIN:         DE0005487904
WKN:          548790
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
GlobeNewswire